{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:35:58Z","timestamp":1781058958116,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.jamda.2011.05.005","type":"journal-article","created":{"date-parts":[[2011,7,15]],"date-time":"2011-07-15T00:13:19Z","timestamp":1310688799000},"page":"189.e1-189.e7","source":"Crossref","is-referenced-by-count":17,"title":["Raloxifene and Tibolone in Elderly Women: A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Trial"],"prefix":"10.1016","volume":"13","author":[{"given":"Didy E.","family":"Jacobsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 J.F.","family":"Melis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald J.J.","family":"Verhaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel G.M.","family":"Olde Rikkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2011.05.005_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2458-5-90","article-title":"The relationship between risk factors for falling and the quality of life in older adults","volume":"5","author":"Ozcan","year":"2005","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jamda.2011.05.005_bib2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/gerona\/61.8.859","article-title":"Handgrip strength and cognitive decline in older Mexican Americans","volume":"61","author":"Alfaro-Acha","year":"2006","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jamda.2011.05.005_bib3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/gerona\/62.8.851","article-title":"Physical fitness and 4-year mortality in an 80-year-old population","volume":"62","author":"Takata","year":"2007","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"10.1016\/j.jamda.2011.05.005_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risk and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2011.05.005_bib5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"280","author":"Hully","year":"1998","journal-title":"JAMA"},{"issue":"suppl 1","key":"10.1016\/j.jamda.2011.05.005_bib6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.maturitas.2004.02.014","article-title":"Tibolone: how does its mechanism of action translate into clinical effects","volume":"48","author":"Kenemans","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.jamda.2011.05.005_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1071\/RD00109","article-title":"Selective estrogen receptor modulators: mechanism of action and clinical experience. Focus on raloxifene","volume":"13","author":"Thiebaud","year":"2001","journal-title":"Reprod Fertil Dev"},{"key":"10.1016\/j.jamda.2011.05.005_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1359\/jbmr.2002.17.2.341","article-title":"Bone histomorphometric and biochemical marker results of a 2-year placebo-controlled trial of raloxifene in postmenopausal women","volume":"17","author":"Ott","year":"2002","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jamda.2011.05.005_bib9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/1745-6215-9-32","volume":"9","author":"Jacobsen","year":"2008","journal-title":"Trials"},{"key":"10.1016\/j.jamda.2011.05.005_bib10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bmj.332.7542.667","article-title":"LIFT study is discontinued","volume":"332","author":"Cummings","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2011.05.005_bib11","series-title":"Het coderen van hetopleidingsnivo","author":"Heslinga","year":"1983"},{"key":"10.1016\/j.jamda.2011.05.005_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1471-0528.2002.01213.x","article-title":"Muscle strength and tibolone: A randomized, double-blind, placebo-controlled trial","volume":"109","author":"Meeuwsen","year":"2002","journal-title":"Br J Obstet Gynaecol"},{"issue":"10","key":"10.1016\/j.jamda.2011.05.005_bib13","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1210\/jcem.86.10.7937","article-title":"Prevention of bone loss with tibolone in postmenopausal women: Results of two randomized, double-blind, placebo-controlled, dose-finding studies","volume":"86","author":"Gallagher","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jamda.2011.05.005_bib14","first-page":"141","article-title":"Handgrip pressure in older people","volume":"20","author":"Anderson","year":"1966","journal-title":"Br J Prev Soc Med"},{"issue":"3","key":"10.1016\/j.jamda.2011.05.005_bib15","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: Evidence for a phenotype","volume":"56A","author":"Fried","year":"2001","journal-title":"J\u00a0Gerontol Ser A Biol Sci Med Sci"},{"key":"10.1016\/j.jamda.2011.05.005_bib16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1359\/jbmr.2002.17.2.341","article-title":"Bone histomorphometric and biochemical marker results of a 2-year placebo-controlled trial of raloxifene in postmenopausal women","volume":"17","author":"Ott","year":"2002","journal-title":"J\u00a0Bone Miner Res"},{"issue":"7","key":"10.1016\/j.jamda.2011.05.005_bib17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"For the Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3 year randomized trial","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2011.05.005_bib18","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1359\/jbmr.1998.13.11.1747","article-title":"Treatment of established postmenopausal osteoporosis with raloxifene: A randomized trial","volume":"13","author":"Lufkin","year":"1998","journal-title":"J\u00a0Bone Miner Res"},{"issue":"23","key":"10.1016\/j.jamda.2011.05.005_bib19","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women","volume":"337","author":"Delmas","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2011.05.005_bib20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S8756-3282(96)00219-0","article-title":"Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: A two-year randomized, placebo-controlled study","volume":"19","author":"Berning","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.jamda.2011.05.005_bib21","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1210\/jc.81.7.2419","article-title":"Tibolone: prevention of bone loss in late postmenopausal women","volume":"81","author":"Bjarnason","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jamda.2011.05.005_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S8756-3282(96)00335-3","article-title":"The response in spinal bone mass to tibolone treatment is related to bone turnover in elderly women","volume":"20","author":"Bjarnson","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.jamda.2011.05.005_bib23","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/bmj.280.6225.1207","article-title":"Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis","volume":"280","author":"Lindsay","year":"1980","journal-title":"Br Med J"},{"key":"10.1016\/j.jamda.2011.05.005_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0378-5122(91)90099-C","article-title":"Non-linear increase in vertebral densitiy induced by a synthetic steroid (ORG OD 14) in women with established osteoporosis","volume":"13","author":"Geusens","year":"1991","journal-title":"Maturitas"},{"key":"10.1016\/j.jamda.2011.05.005_bib25","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1210\/jc.86.10.4717","article-title":"Prevention of bone loss with tibolone in postmenopausal women: Results of two randomized, double blind, placebo-controlled, dose-finding studies","volume":"86","author":"Gallagher","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.jamda.2011.05.005_bib26","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0800743","article-title":"The effects of tibolone in older postmenopausal women","volume":"359","author":"Cummings","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.jamda.2011.05.005_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/gme.0b013e3181e9d833","article-title":"Low-dose tibolone (1.25 mg\/d) does not affect muscle strength in older women","volume":"18","author":"Ribom","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.jamda.2011.05.005_bib28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s004240050392","article-title":"Decline in isokinetic force with age: muscle cross-sectional area and specific force","volume":"434","author":"Jubrias","year":"1997","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jamda.2011.05.005_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1152\/advan.90111.2008","article-title":"Skeletal muscle and bone: Effect of sex steroids and ageing","volume":"32","author":"Brown","year":"2008","journal-title":"Adv Physiol Educ"},{"key":"10.1016\/j.jamda.2011.05.005_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/gerona\/58.1.B3","article-title":"Morphological and functional characteristics of skeletal muscle fibers from hormone-replaced and nonreplaced postmenopausal women","volume":"58","author":"Widrick","year":"2003","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jamda.2011.05.005_bib31","doi-asserted-by":"crossref","first-page":"M204","DOI":"10.1093\/geronj\/47.6.M204","article-title":"Knee extensor and knee flexor strength: cross-sectional area ratios in young and elderly men","volume":"47","author":"Overend","year":"1992","journal-title":"J\u00a0Gerontol"},{"issue":"suppl","key":"10.1016\/j.jamda.2011.05.005_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1507\/endocrj1954.26.Supplement_65","article-title":"Osteomalacic myopathy","volume":"26","author":"Yoshikawa","year":"1979","journal-title":"Endocrinol Jpn"},{"issue":"2","key":"10.1016\/j.jamda.2011.05.005_bib33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/gme.0b013e3181bd54df","article-title":"Raloxifene improves verbal memory in late postmenopausal women: A randomised, double-blind, placebo-controlled trial","volume":"17","author":"Jacobsen","year":"2010","journal-title":"Menopause J N Am Menopause Soc"},{"issue":"1","key":"10.1016\/j.jamda.2011.05.005_bib34","first-page":"CD003122","article-title":"Hormone replacement therapy for cognitive function in postmenopausal women","volume":"23","author":"Lethaby","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.jamda.2011.05.005_bib35","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1210\/en.142.11.4813","article-title":"The effect of tibolone on fat mass, fat-free mass, and total body water in postmenopausal women","volume":"142","author":"Meeuwsen","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.jamda.2011.05.005_bib36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1365-2265.1998.00481.x","article-title":"Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women","volume":"48","author":"H\u00e4nggi","year":"1998","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.jamda.2011.05.005_bib37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.maturitas.2004.09.003","article-title":"Effects of tibolone on body composition in postmenopausal women: A 1 year follow up study","volume":"51","author":"Boyanov","year":"2005","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.jamda.2011.05.005_bib38","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/01.gme.0000227335.27996.d8","article-title":"Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene","volume":"13","author":"Tommaselli","year":"2006","journal-title":"Menopause"},{"issue":"8","key":"10.1016\/j.jamda.2011.05.005_bib39","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/humrep\/deg331","article-title":"Changes in body composition during post-menopausal hormone therapy: A 2 year prospective study","volume":"18","author":"Arabi","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jamda.2011.05.005_bib40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-55-1-33","article-title":"Factors of risk in development of coronary heart disease\u2014Six year follow-up experience. The Framingham Study","volume":"55","author":"Kannel","year":"1961","journal-title":"Ann Intern Med"},{"issue":"(4)Pt 2","key":"10.1016\/j.jamda.2011.05.005_bib41","first-page":"52","article-title":"The Framingham study: A prospective study of coronary heart disease","volume":"21","author":"Kagan","year":"1962","journal-title":"Fed Proc"},{"key":"10.1016\/j.jamda.2011.05.005_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1076-7460.2002.00995.x","article-title":"Coronary heart disease risk factors in elderly","volume":"11","author":"Kannel","year":"2002","journal-title":"Am J Geriatr Cardiol"},{"key":"10.1016\/j.jamda.2011.05.005_bib43","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.CIR.83.1.356","article-title":"An updated coronary risk profile: A statement for health-professionals","volume":"83","author":"Anderson","year":"1991","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jamda.2011.05.005_bib44","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.amjmed.2009.01.033","article-title":"Raloxifene And Risk For Stroke Based On Framingham Stroke Risk Score","volume":"122","author":"Barrett-Connor","year":"2009","journal-title":"Am J Med"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861011001940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861011001940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T02:23:19Z","timestamp":1638066199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861011001940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1525861011001940"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2011.05.005","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}